BioLineRx (BLRX) Other Accumulated Expenses (2011 - 2026)
BioLineRx (BLRX) posted Other Accumulated Expenses of $2.21 million for the quarter ended Jun 30, 2026, down 20.3% from $2.77 million a year earlier and down 1.9% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
As of Dec 31, 2025, BioLineRx's Other Accumulated Expenses came in at $1.74 million, down 44.3% from the prior year.
- Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 3.9% (years ended Dec 2020 to Dec 2025).
- In prior years, BioLineRx's Other Accumulated Expenses was $3.13 million in the year ended Dec 31, 2024, -$25.27 million in the year ended Dec 31, 2023, -$6.46 million in the year ended Dec 31, 2022 and $1.23 million in the year ended Dec 31, 2021 (-14.8%).
- Quarterly Other Accumulated Expenses has run from a low of -$25.27 million in the quarter ended Dec 31, 2023 to a high of $3.13 million in the quarter ended Dec 31, 2024 over five years.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $2.25 million (quarter ended Mar 31, 2026), $1.74 million (quarter ended Dec 31, 2025) and $2.13 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | BioLineRx | 6.06 Bn | 6.06 Bn | 235,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.21 Mn |
| Mar 31, 2026 | 2.25 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | 2.13 Mn |
| Jun 30, 2025 | 2.77 Mn |
| Mar 31, 2025 | 1.75 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Sep 30, 2024 | -18.31 Mn |
| Jun 30, 2024 | -12.76 Mn |
| Mar 31, 2024 | -6.34 Mn |
| Dec 31, 2023 | -25.27 Mn |
| Sep 30, 2023 | -17.61 Mn |
| Jun 30, 2023 | -9.48 Mn |
| Mar 31, 2023 | -3.87 Mn |
| Dec 31, 2022 | -6.46 Mn |
| Sep 30, 2022 | -3.11 Mn |
| Jun 30, 2022 | -1.80 Mn |
| Mar 31, 2022 | 1.26 Mn |
| Dec 31, 2021 | -1.00 Mn |
| Sep 30, 2021 | 1.13 Mn |
API Access
BioLineRx Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();